ACM
WGSWW

Arrow Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Arrow Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,999
Closed -$74K – 12
2021
Q3 		$74K Hold
34,999
– – 0.05% 11
2021
Q2 		$161K Buy
+34,999
New +$150K 0.11% 14

Other funds holding WGSWW

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Arrow Capital Management's WGSWW Position: Q4 2021 in Review

Arrow Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q4 2021, closing a stake of 34,999 shares — an estimated $74K sold.

Arrow Capital Management first reported a position in WGSWW in Q2 2021 and held it in 2 quarters. The position peaked at $161K in Q2 2021. 33 funds tracked by Wall St. Rank hold WGSWW as of Q4 2021.

  • Arrow Capital Management reported no remaining GeneDx Holdings Warrant position as of Q4 2021 after selling out during the quarter.
  • Arrow Capital Management sold 34,999 GeneDx Holdings Warrant shares in Q4 2021, an estimated $74K.
  • Arrow Capital Management first reported a position in GeneDx Holdings Warrant in Q2 2021 and held it in 2 quarters.
  • Arrow Capital Management's GeneDx Holdings Warrant position peaked at $161K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q4 2021.

Based on Arrow Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.